GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sudeep Pharma Ltd
Sudeep Pharma Appoints Milin Mehta as Additional Director
MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 26 Jun 2026, 04:12 PM IST  ·  BSE ID: 2eca16e6-dbba-4ad7-af5a-6917743c7fda
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has added a new director, Mr. Milin Mehta, who will not be involved in day-to-day operations but has directorial influence.
🤖 AI Summary
  • Sudeep Pharma Board appoints Mr. Milin Mehta as Additional Director.
  • Mr. Mehta will serve as Non-Executive & Non-Independent Director.
  • Appointment is effective from June 26, 2026, subject to shareholder approval.
  • Director is not debarred by SEBI or any other Authority.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholders will vote on the appointment at the next general meeting.
👤
Who Is Affected
All shareholders are affected as the composition of the Board of Directors is changing, which may influence future corporate strategy.
🔍
Management Signal
The appointment signals management's intent to potentially leverage external expertise and strengthen board oversight.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Shareholder meeting outcome regarding director appointment.
Disclosure of Mr. Milin Mehta's directorship experience details.
Future board meeting outcomes under new director's tenure.
LOW RISK Director appointment is a standard corporate governance procedure.
💡 Investor Takeaway
Sudeep Pharma Limited's Board appointed Mr. Milin Mehta as an Additional Director (Non-Executive & Non-Independent), effective June 26, 2026, subject to shareholder approval.
❓ Frequently Asked Questions
Who has been appointed as a director at Sudeep Pharma Limited?
Mr. Milin Mehta has been appointed as an Additional Director (Non-Executive & Non-Independent) at Sudeep Pharma Limited.
When is the new director appointment effective for Sudeep Pharma?
The appointment of Mr. Milin Mehta is effective from June 26, 2026.
What type of director is Mr. Milin Mehta at Sudeep Pharma?
Mr. Milin Mehta is appointed as a Non-Executive and Non-Independent Director.
Is shareholder approval required for Mr. Milin Mehta's appointment?
Yes, the appointment of Mr. Milin Mehta is subject to the approval of the shareholders of Sudeep Pharma Limited.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.